Matches in SemOpenAlex for { <https://semopenalex.org/work/W2977096572> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W2977096572 endingPage "113" @default.
- W2977096572 startingPage "107" @default.
- W2977096572 abstract "Major problems haunt the physicians who need to delineate the best management strategy for their patients with thyroid nodule is the identification of the most aggressive cases, especially among papillary thyroid cancers, which would benefit from more aggressive therapy and follow up. Beyond its strong correlation with PTC, the BRAF mutation is well described to associate with poor prognosis. The aim of our study was to identify BRAF antibody expression in different hystotypes of the thyroid nodules and assessment of it expression according to the tumor aggressiveness. Immunohistochemical staining was performed in 54 of surgically resected thyroid nodules, including malignant and benign cases, grouped according to the tumor aggressiveness. We have used selected thyroid specific markers: BRAF antibody, CD-56, CK-19, HBME-1 and KI-67. Adenomatous hyperplasia's and follicular lesions doesn't reveal positivity to the expression of BRAF antibody. Encapsulated papillary carcinomas included in our work revealed negative or very poor positivity of BRAF antibody. This fact strengthen the hypothesis that encapsulated papillary carcinomas have an indolent behavior and is genetically distinct from infiltrative tumors. We revealed 55,5% positivity of BRAF antibody in the cases of papillary microcarcinomas, this fact creates a need for more cautious approach to this type of tumors. The degree of BRAF antibody expression increased with a rising of tumor aggressiveness in our histopathologic groups (P<0,005). All cases of papillary carcinoma with multinodular involvement and extrathyroid extension revealed moderate or strong positivity of BRAF antibody expression." @default.
- W2977096572 created "2019-10-03" @default.
- W2977096572 creator A5061991615 @default.
- W2977096572 creator A5064619880 @default.
- W2977096572 creator A5082674272 @default.
- W2977096572 date "2017-10-01" @default.
- W2977096572 modified "2023-09-23" @default.
- W2977096572 title "BRAF ANTIBODY EXPRESSION IN DIFFERENT TYPES OF THYROID NODULAR LESIONS." @default.
- W2977096572 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29099711" @default.
- W2977096572 hasPublicationYear "2017" @default.
- W2977096572 type Work @default.
- W2977096572 sameAs 2977096572 @default.
- W2977096572 citedByCount "0" @default.
- W2977096572 crossrefType "journal-article" @default.
- W2977096572 hasAuthorship W2977096572A5061991615 @default.
- W2977096572 hasAuthorship W2977096572A5064619880 @default.
- W2977096572 hasAuthorship W2977096572A5082674272 @default.
- W2977096572 hasConcept C126322002 @default.
- W2977096572 hasConcept C142724271 @default.
- W2977096572 hasConcept C151730666 @default.
- W2977096572 hasConcept C159654299 @default.
- W2977096572 hasConcept C203014093 @default.
- W2977096572 hasConcept C204232928 @default.
- W2977096572 hasConcept C2776731575 @default.
- W2977096572 hasConcept C2779022025 @default.
- W2977096572 hasConcept C2993294228 @default.
- W2977096572 hasConcept C2993477687 @default.
- W2977096572 hasConcept C526584372 @default.
- W2977096572 hasConcept C71924100 @default.
- W2977096572 hasConcept C86803240 @default.
- W2977096572 hasConceptScore W2977096572C126322002 @default.
- W2977096572 hasConceptScore W2977096572C142724271 @default.
- W2977096572 hasConceptScore W2977096572C151730666 @default.
- W2977096572 hasConceptScore W2977096572C159654299 @default.
- W2977096572 hasConceptScore W2977096572C203014093 @default.
- W2977096572 hasConceptScore W2977096572C204232928 @default.
- W2977096572 hasConceptScore W2977096572C2776731575 @default.
- W2977096572 hasConceptScore W2977096572C2779022025 @default.
- W2977096572 hasConceptScore W2977096572C2993294228 @default.
- W2977096572 hasConceptScore W2977096572C2993477687 @default.
- W2977096572 hasConceptScore W2977096572C526584372 @default.
- W2977096572 hasConceptScore W2977096572C71924100 @default.
- W2977096572 hasConceptScore W2977096572C86803240 @default.
- W2977096572 hasIssue "271" @default.
- W2977096572 hasLocation W29770965721 @default.
- W2977096572 hasOpenAccess W2977096572 @default.
- W2977096572 hasPrimaryLocation W29770965721 @default.
- W2977096572 hasRelatedWork W1608118181 @default.
- W2977096572 hasRelatedWork W2158446555 @default.
- W2977096572 hasRelatedWork W2166113377 @default.
- W2977096572 hasRelatedWork W2342369347 @default.
- W2977096572 hasRelatedWork W2382761982 @default.
- W2977096572 hasRelatedWork W2403914000 @default.
- W2977096572 hasRelatedWork W2417576622 @default.
- W2977096572 hasRelatedWork W2470741484 @default.
- W2977096572 hasRelatedWork W4210537256 @default.
- W2977096572 hasRelatedWork W4290629096 @default.
- W2977096572 isParatext "false" @default.
- W2977096572 isRetracted "false" @default.
- W2977096572 magId "2977096572" @default.
- W2977096572 workType "article" @default.